Form: 10-Q

Quarterly report pursuant to Section 13 or 15(d)

November 5, 2019

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2019

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to            

 

Commission file number: 001-36404

 

INPIXON

(Exact name of registrant as specified in its charter)

 

Nevada   88-0434915
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

2479 Bayshore Road
Suite 195
Palo Alto, CA
  94303
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:  (408) 702-2167

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Securities registered pursuant to Section 12(b) of the Act:

  

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   INPX   The Nasdaq Capital Market

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Common Stock, par value $0.001  

66,314,768

(Class)   Outstanding at October 31, 2019

   

 

 

 

 

 

INPIXON

 

FORM 10-Q FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2019

 

TABLE OF CONTENTS

 

  Page No.
   
Special Note Regarding Forward-Looking Statements and Other Information Contained in this Report ii
   
PART I - FINANCIAL INFORMATION 1
     
Item 1. Financial Statements 1
     
  Condensed Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018 2-3
     
  Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2019 and 2018 4
     
  Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2019 and 2018 5
     
  Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2018 and 2019 6-7
     
  Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019 and 2018 8
     
  Notes to Unaudited Condensed Consolidated Financial Statements 9
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 33
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 51
     
Item 4. Controls and Procedures 51
     
PART II - OTHER INFORMATION 52
     
Item 1. Legal Proceedings 52
     
Item 1A. Risk Factors 52
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 55
     
Item 3. Defaults Upon Senior Securities 55
     
Item 4. Mine Safety Disclosure 55
     
Item 5. Other Information 55
     
Item 6. Exhibits 55
     
Signatures 56

 

i

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

AND OTHER INFORMATION CONTAINED IN THIS REPORT

 

This Quarterly Report on Form 10-Q (this “Form 10-Q”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. You can find many (but not all) of these statements by looking for words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “would,” “should,” “could,” “may” or other similar expressions in this Form 10-Q. In particular, these include statements relating to future actions; prospective products, applications, customers and technologies; future performance or results of anticipated products; anticipated expenses; and projected financial results. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations or projections. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to:

 

  our limited cash and our history of losses;
     
  our ability to achieve profitability;

 

  our limited operating history with recent acquisitions;

 

  risks related to our acquisition of Jibestream Inc.;

 

  our ability to successfully integrate companies we acquire;
     
  emerging competition and rapidly advancing technology in our industry that may outpace our technology;

 

  customer demand for the products and services we develop;

 

  the impact of competitive or alternative products, technologies and pricing;

 

  our ability to manufacture any products we develop;

 

  general economic conditions and events and the impact they may have on us and our potential customers;

 

  our ability to obtain adequate financing in the future;

 

  our ability to continue as a going concern;

 

  our ability to consummate strategic transactions, which may include acquisitions, mergers, dispositions or investments;

 

  lawsuits and other claims by third parties or investigations by various regulatory agencies that we are required to report to including the uncertainty relating to the ongoing U.S. Securities and Exchange Commission investigation;
     
  the impact of a delisting from the Nasdaq Stock Market if we are not able to organically cure the existing bid price deficiency prior to November 26, 2019 and our ability to maintain compliance with other continued listing requirements;

 

  our success at managing the risks involved in the foregoing items; and

 

  other factors discussed in this Form 10-Q.

 

ii

 

 

We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included in this Form 10-Q, particularly in the “Risk Factors” section, that we believe could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make or collaborations or strategic partnerships we may enter into.

 

You should read this Form 10-Q and the documents that we have filed as exhibits to this Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. We do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Unless otherwise stated or the context otherwise requires, the terms “Inpixon,” “we,” “us,” “our” and the “Company” refer collectively to Inpixon and its subsidiaries.

 

Note Regarding Reverse Stock Splits

 

Except where indicated, all share and per share data in this Form 10-Q, including the unaudited condensed consolidated financial statements, reflect the 1-for-15 reverse stock split of the Company’s issued and outstanding common stock effected on March 1, 2017, the 1-for-30 reverse stock split of the Company’s issued and outstanding common stock effected on February 6, 2018 and the 1-for-40 reverse stock split of the Company’s issued and outstanding common stock effected on November 2, 2018.

 

iii

 

 

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information which are the accounting principles that are generally accepted in the United States of America and in accordance with the instructions for Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.

 

In the opinion of management, the condensed consolidated financial statements contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

 

The results for the period ended September 30, 2019 are not necessarily indicative of the results of operations for the full year. These financial statements and related notes should be read in conjunction with the consolidated financial statements and notes thereto included in our audited consolidated financial statements for the fiscal years ended December 31, 2018 and 2017 included in the annual report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 28, 2019.

 

1

 

 

INPIXON AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(In thousands, except number of shares and par value data)

 

    As of     As of  
    September 30,
2019
    December 31,
2018
 
    (Unaudited)     (Audited)  
Assets            
             
Current Assets            
Cash and cash equivalents   $ 494     $ 1,008  
Accounts receivable, net     2,451       1,280  
Notes and other receivables     219       4  
Inventory     764       568  
Prepaid assets and other current assets     607       496  
                 
Total Current Assets     4,535       3,356  
                 
Property and equipment, net     138       202  
Operating lease right-of-use asset, net     736       --  
Software development costs, net     1,566       1,690  
Intangible assets, net     9,338       4,509  
Goodwill     3,097       --  
Loan to related party     10,366       2,204  
Receivable from related party     601       --  
Other assets     114       217  
                 
Total Assets   $ 30,491     $ 12,178  

 

The accompanying notes are an integral part of these financial statements.

 

2

 

 

INPIXON AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

 

(In thousands, except number of shares and par value data)

 

    As of     As of  
    September 30,
2019
    December 31,
2018
 
    (Unaudited)     (Audited)  
Liabilities and Stockholders’ Equity            
             
Current Liabilities            
Accounts payable   $ 2,333     $ 1,129  
Accrued liabilities     1,401       1,792  
Operating lease obligation     440       --  
Deferred revenue     1,051       234  
Short-term debt     10,059       4,127  
Acquisition liability     952       --  
                 
Total Current Liabilities     16,236       7,282  
                 
Long Term Liabilities                
Long-term debt     --       74  
Operating lease obligation, noncurrent     317       --  
Other liabilities     7       19  
Deferred tax liability, noncurrent     1,696       --  
Acquisition liability, noncurrent     750       --  
                 
Total Liabilities     19,006       7,375  
                 
Commitments and Contingencies                
                 
Stockholders’ Equity                
                 

Preferred Stock - $0.001 par value; 5 mill shares authorized, consisting of Series 4 Convertible Pref Stock - 10,415 shares authorized; 1 and 1 issued, and 1 and 1 outstanding as of Sept 30, 2019 and Dec 31, 2018, respectively, and Series 5 Convertible Pref Stock - 12,000 shares authorized; 126 and 0 issued, and 126 and 0 outstanding as of Sept 30, 2019 and Dec 31, 2018, respectively.

    --       --  
Common Stock - $0.001 par value; 250,000,000 shares authorized; 50,518,513 and 1,581,893 issued and 50,518,500 and 1,581,880 outstanding as of September 30, 2019 and December 31, 2018, respectively.     51       2  
Additional paid-in capital     146,854       123,224  
Treasury stock, at cost, 13 shares     (695 )     (695 )
Accumulated other comprehensive income     (10 )     26  
Accumulated deficit (excluding $2,442 reclassified to additional paid in capital in quasi-reorganization)     (134,741 )     (117,772 )
                 
Stockholders’ Equity Attributable to Inpixon     11,459       4,785  
                 
Non-controlling Interest     26       18  
                 
Total Stockholders’ Equity     11,485       4,803  
                 
Total Liabilities and Stockholders’ Equity   $ 30,491     $ 12,178  

  

The accompanying notes are an integral part of these financial statements.

 

3

 

 

INPIXON AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(In thousands, except per share data)

 

    For the Three Months Ended     For the Nine Months Ended  
    September 30,     September 30,  
    2019     2018     2019     2018  
    (Unaudited)     (Unaudited)  
Revenues   $ 1,534     $ 940     $ 4,387     $ 2,627  
                                 
Cost of Revenues     382       298       1,109       818  
                                 
Gross Profit     1,152       642       3,278       1,809  
                                 
Operating Expenses                                
Research and development     926       296       2,677       820  
Sales and marketing     847       447       2,161       1,259  
General and administrative     3,521       2,326       9,890       8,796  
Acquisition related costs     573       78       1,220       94  
Amortization of intangibles     969       812       2,602       2,419  
                                 
Total Operating Expenses     6,836       3,959       18,550       13,388  
                                 
Loss from Operations     (5,684 )     (3,317 )     (15,272 )     (11,579 )
                                 
Other Income (Expense)                                
Interest expense     (1,190 )     (78 )     (2,053 )     (981 )
Loss on exchange of debt for equity     (27 )     --       (188 )     --  
Change in fair value of derivative liability     --       --       --       48  
Gain on the sale of Sysorex Arabia     --       --       --       23  
Other income/(expense)     289       --       518       (11 )
                                 
Total Other Income (Expense)     (928 )     (78 )     (1,723 )     (921 )
                                 
Net Loss from Continuing Operations, before tax     (6,612 )     (3,395 )     (16,995 )     (12,500 )
    Income tax benefit     33       --       35       --  
Net Loss from Continuing Operations     (6,579 )     (3,395 )     (16,960 )     (12,500 )
                                 
Loss from Discontinued Operations, Net of Tax     --       (1,785 )     --       (4,778 )
                                 
Net Loss     (6,579 )     (5,180 )     (16,960 )     (17,278 )
                                 
Net Income/(Loss) Attributable to Non-controlling Interest     5       4       9       6  
                                 
Net Loss Attributable to Stockholders of Inpixon   $ (6,584 )   $ (5,184 )   $ (16,969 )   $ (17,284 )
                                 
Deemed dividend to preferred stockholders     --       --       --       (11,235 )
Deemed dividend for triggering of warrant down round feature     --       --       (1,250 )     --  
Net Loss Attributable to Common Stockholders     (6,584 )     (5,184 )     (18,219 )     (28,519 )
                                 
Net Loss Per Basic and Diluted Common Share                                
Loss from continuing operations   $ (0.28 )   $ (3.17 )   $ (1.46 )   $ (45.97 )
Loss from discontinued operations   $ --     $ (1.67 )   $ --     $ (9.25 )
Net Loss Per Share - Basic and Diluted   $ (0.28 )   $ (4.84 )   $ (1.46 )   $ (55.24 )
                                 
Weighted Average Shares Outstanding                                
Basic and Diluted     23,366,543       1,071,310       12,442,450       516,302  

  

The accompanying notes are an integral part of these financial statements.

 

4

 

 

INPIXON AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

(In thousands)

 

    For the Three Months Ended     For the Nine Months Ended  
    September 30,     September 30,  
    2019     2018     2019     2018  
    (Unaudited)     (Unaudited)  
                         
Net Loss   $ (6,579 )   $ (5,180 )   $ (16,960 )   $ (17,278 )
                                 
Unrealized foreign exchange gain/(loss) from cumulative translation adjustments     (67 )     (10 )     (36 )     (15 )
                                 
Comprehensive Loss   $ (6,646 )   $ (5,190 )   $ (16,996 )   $ (17,293 )

 

The accompanying notes are an integral part of these financial statements.

 

5

 

 

INPIXON AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2019

 

(Unaudited)

 

(In thousands, except per share data)

 

    Series 3 Convertible     Series 4 Convertible     Series 5 Convertible     Series 6 Convertible           Additional                 Accumulated
Other Comprehensive
          Non-     Total
Stockholders’
 
    Preferred Stock     Preferred Stock     Preferred Stock     Preferred Stock     Common Stock     Paid-In     Treasury Stock     Income     Accumulated     Controlling     (Deficit)  
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Capital     Shares     Amount     (Loss)     Deficit     Interest     Equity  
                                                                                                       
Balance - January 1, 2018     --     $ --       --     $ --       --     $ --       --     $ --       24,055     $ --     $ 78,303       (13 )   $ (695 )   $ 31     $ (94,484 )   $ (2,006 )   $ (18,851 )
                                                                                                                                         
Common shares issued for services     --       --       --       --       --       --       --       --       196       --       80       --       --       --       --       --       80  
Stock options granted to employees for services     --       --       --       --       --       --       --       --       --       --       206       --       --       --       --       --       206  
Fractional shares issued for stock split     --       --       --       --       --       --       --       --       243       --       -       --       --       --       --       --       --  
Common and preferred shares issued for net cash proceeds from a public offering     4,105.5252       --       --       --       --       --       --       --       98,145       --       18,942       --       --       --       --       --       18,942  
Redemption of convertible series 3 preferred stock     (3,694.2752 )     --       --       --       --       --       --       --       39,301       --       --       --       --       --       --       --       --  
Common shares issued for extinguishment of debenture liability     --       --       --       --       --       --       --       --       6,881       --       1,456       --       --       --       --       --       1,456  
Sale of Sysorex Arabia     --       --       --       --       --       --       --       --       --       --       --       --       --       --       --       2,013       2,013  
Adoption of accounting standards (Note 2)     --       --       --       --       --       --       --       --       --       --       --       --       --       --       1,287       --       1,287  
Cumulative Translation Adjustment     --       --       --       --       --       --       --       --       --       --       --       --       --       (7 )     --       --       (7 )
Net loss     --       --       --       --       --       --       --       --       --       --       --       --       --       --       (6,244 )     --       (6,244 )
                                                                                                                                         
Balance - March 31, 2018     411.2500     $ --       --     --     --     --     --     $ --       168,821     --     98,987     (13 )   (695 )   $ 24     (99,441 )   7     (1,118 )
                                                                                                                                         
Stock options granted to employees for services     --       --       --       --       --       --       --       --       --       --       571       --       --       --       --       --     571  
Common and preferred shares issued for net cash proceeds from a public offering     --       --       10,115.0000       --       --       --       --       --       --       --       9,021       --       --       --       --       --     9,021  
Redemption of convertible series 3 preferred stock     (411.2500 )     --       --       --       --       --       --       --       69,050       --       (2 )     --       --       --       --       --     (2
Redemption of convertible series 4 preferred stock     --        --        (7,796.7067 )     --       --       --       --       --       718,452       1       (1 )     --       --       --       --       --     --  
Cumulative Translation Adjustment     --       --       --       --       --       --       --       --       --       --       --       --       --       2       --       --     2  
Net loss     --     --       --     --       --     --       --       --       --       --       --       --       --       --       (5,857 )     2     (5,855 )
                                                                                                                                         
Balance - June 30, 2018     --     $ --       2,318.2933     $ --       --     $ --       --     $ --       956,323     $ 1     108,576       (13 )   $ (695 )   $ 26     $ (105,298 )   $ 9     $ 2,619  
                                                                                                                                         
Stock options granted to employees for services     --       --       --       --       --       --       --       --       --       --       122       --       --       --       --       --     122  
Redemption of convertible series 4 preferred stock     --       --       (2,311.2933 )     --       --       --       --       --       324,803       --       --   --       --       --       --       --     --  
Deconsolidation of Sysorex as a result of spin-off     --       --       --       --       --       --       --       --       --       --       11,476       --       --       --       --       --     11,476  
Cumulative Translation Adjustment     --       --       --       --       --       --       --       --       --       --       --       --       --       (10 )     --       --     (10 )
Net loss     --       --       --       --       --       --       --       --       --       --       --       --       --       --       (5,184 )     4     (5,180 )
                                                                                                                                         
Balance - September 30, 2018     --     $ --       7     $ --       --     $ --       --     $ --       1,281,126     $ 1     $ 120,174       (13 )   $ (695 )   $ 16     $ (110,482 )   $ 13     $ 9,027  

 

The accompanying notes are an integral part of these financial statements.

 

6

 

 

INPIXON AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 AND 2019

(CONTINUED) 

 

(Unaudited)

(In thousands, except per share data)

 

    Series 3 Convertible     Series 4 Convertible     Series 5 Convertible     Series 6 Convertible           Additional                 Accumulated
Other Comprehensive
          Non-     Total
Stockholders’
 
    Preferred Stock     Preferred Stock     Preferred Stock     Preferred Stock     Common Stock     Paid-In     Treasury Stock     Income     Accumulated     Controlling     (Deficit)  
    Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Shares     Amount     Capital     Shares     Amount     (Loss)     Deficit     Interest     Equity  
                                                                                                       
Balance - January 1, 2019     --     $ --       1     $ --       --     $ --       --     $ --       1,581,893     $ 2     $ 123,224       (13 )   $ (695 )   $ 26     $ (117,773 )   $ 18     $ 4,802  
                                                                                                                                         
Preferred Shares issued for net cash proceeds of a public offering     --       --       --       --       12,000       --       --       --       --       --       10,814       --       --       --       --       --       10,814  
Common shares issued for extinguishment of debt     --       --       --       --       --       --       --       --       172,869       --       384       --       --       --       --       --       384  
Common shares issued for net proceeds from warrants exercised     --       --       --       --       --       --       --       --       13,761       --       46       --       --       --       --       --       46  
Common shares issued for warrants exercised     --       --       --       --       --       --       --       --       1,248,324       1       (1 )     --       --       --       --       --       --  
Redemption of convertible Series 5 Preferred Stock     --       --       --       --       (10,062 )     --       --       --       3,021,663       3       (3 )     --       --       --       --       --       --  
Common shares issued for extinguishment of liability     --       --       --       --       --       --       --       --       749,440       1       1,129       --       --       --       --       --       1,130  
Common shares issued for services     --       --       --       --       --       --       --       --       200,000       --       242       --       --       --       --       --       242  
Stock options granted to employees and consultants for services     --       --       --       --       --       --       --       --       --       --       648       --       --       --       --       --       648  
Cumulative Translation Adjustment     --       --       --       --       --       --       --       --       --       --       --       --       --       (8 )     --       --       (8 )
Net loss     --       --       --       --       --       --       --       --       --       --       --       --       --       --       (5,144 )     (5 )     (5,149 )
                                                                                                                                         
Balance - March 31, 2019     --     $ --       1     $ --       1,938     $ --       --     $ --       6,987,950     $ 7     $ 136,483       (13 )   $ (695 )   $ 18     $ (122,917 )   $ 13     $ 12,909  
                                                                                                                                         
Common shares issued for extinguishment of debt     --       --       --       --       --       --       --       --       2,773,607       3       2,002       --       --       --       --       --       2,005  
Common shares issued for warrants exercised     --       --       --       --       --       --       --       --       835,740       1       (1 )     --       --       --       --       --       --  
Redemption of convertible Series 5 Preferred Stock     --       --       --       --       (1,812 )     --       --       --       544,145       1       (1 )     --       --       --       --       --       --  
Stock options granted to employees and consultants for services     --       --       --       --       --       --       --       --       --       --       858       --       --       --       --       --       858  
Issuance of Locality Acquisition Shares     --       --       --       --       --       --       --       --       650,000       --       513       --       --       --       --       --       513  
Issuance of GTX Acquisition Shares     --       --       --       --       --       --       --       --       1,000,000       1       649       --       --       --       --       --       650  
Cumulative Translation Adjustment     --       --       --       --       --       --       --       --       --       --       --       --       --       39       --       --       39  
Net loss     --       --       --       --       --       --       --       --       --       --       --       --       --       --       (5,240 )     9       (5,231 )
                                                                                                                                         
Balance - June 30, 2019     --     $ --       1     $ --       126     $ --       --     $ --       12,791,442     $ 13     $ 140,503       (13 )   $ (695 )   $ 57     $ (128,157 )   $ 22     $ 11,743  
                                                                                                                                         
Common shares issued for extinguishment of debt     --       --       --       --       --       --       --       --       1,403,772       1       723       --       --       --       --       --       724  
Common shares issued for warrants exercised     --       --       --       --       --       --       --       --       13,956,909       14       (14 )     --       --       --       --       --       --  
Stock options granted to employees and consultants for services     --       --       --       --       --       --       --       --       --       --       872       --       --       --       --       --       872  
Issuance of Jibestream Acquisition Shares     --       --       --       --       --       --       --       --       5,068,969       5       857       --       --       --       --       --       862  
Common and Preferred Shares issued for net cash proceeds of a public offering     --       --       --       --       --       --       2,997       3       6,497,410       7       3,924       --       --       --       --       --       3,934  
Redemption of convertible Series 6 Preferred Stock     --       --       --       --       --       --       (2,997 )     (3 )     10,800,011       11       (11 )     --       --       --       --       --       (3 )
Cumulative Translation Adjustment     --       --       --       --       --       --       --       --       --       --       --       --       --       (67 )     --       --       (67 )
Net loss     --       --       --       --       --       --       --       --       --       --       --       --       --       --       (6,584 )     4       (6,580 )
                                                                                                                                         
Balance - September 30, 2019     --     $ --       1     $ --       126     $ --       --     $ --       50,518,513     $ 51     $ 146,854       (13 )   $ (695 )   $ (10 )   $ (134,741 )   $ 26     $ 11,485  

 

The accompanying notes are an integral part of these financial statements.

 

7

 

 

INPIXON AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(In thousands)

 

    For the Nine Months Ended  
    September 30,  
    2019     2018  
    (Unaudited)  
Cash Flows (Used In) from Operating Activities            
Net loss   $ (16,960 )   $ (17,278 )
Adjustment to reconcile net loss to net cash used in operating activities:                
Depreciation and amortization     826       1,334  
Amortization of intangible assets     2,602       3,804  
Amortization of right of use asset     267       --  
Stock based compensation     2,618       979  
Amortization of technology     50       50  
Loss on exchange of debt for equity     188       --  
Change in fair value of derivative liability     --       (48 )
Amortization of debt discount     1,543       417  
Provision for doubtful accounts     358       221  
Gain on earnout     --       (934 )
Gain on the settlement of liabilities     --       (307 )
Gain on the sale of Sysorex Arabia     --       (23 )
Income tax benefit     (35 )     --  
Other     23       (37 )
                 
Changes in operating assets and liabilities:                
Accounts receivable and other receivables     (1,241 )     207  
Inventory     (194 )     (19 )
Other current assets     (45 )     54  
Prepaid licenses and maintenance contracts     --       (5 )
Other assets     (284 )     (36 )
Accounts payable     1,140       (8,797 )
Accrued liabilities     56       (3,057 )
Deferred revenue     (369 )     64  
Other liabilities     400       (44 )
Total Adjustments     7,903       (6,177 )
                 
Net Cash Used in Operating Activities     (9,057 )     (23,455 )
                 
Cash Flows Used in Investing Activities                
Purchase of property and equipment     (58 )     (39 )
Investment in capitalized software     (658 )     (661 )
Investment in Athentek     --       (175 )
Cash spun off as a result of de-consolidation     --       (362 )
Cash paid for acquisition of GTX     (250 )     --  
Cash paid for acquisition of Locality     (204 )     --  
Cash paid for acquisition of Jibestream     (3,714 )     --  
Net Cash Flows Used in Investing Activities     (4,884 )     (1,237 )
                 
Cash Flows From (Used in) Financing Activities                
Net proceeds (repayments) to bank facility     237       (1,141 )
Net proceeds from issuance of common stock, preferred stock and warrants     14,791       27,961  
Repayment of notes payable     (71 )     (113 )
Loans to related party     (9,866 )     (774 )
Repayments from related party     1,683       24  
Advances to related party     (15 )     --  
Loan to Jibestream     (141 )     --  
Loan to GTX     (50 )     --  
Net proceeds from promissory notes     6,750       --  
Net Cash Provided By Financing Activities     13,318       25,957  
                 
Effect of Foreign Exchange Rate on Changes on Cash     (36 )     (15 )
                 
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash     (659 )     1,250  
                 
Cash, Cash Equivalents and Restricted Cash - Beginning of period     1,224       351  
                 
Cash, Cash Equivalents and Restricted Cash - End of period (Note 3)   $ 565     $ 1,601  
                 
Supplemental Disclosure of cash flow information:                
Cash paid for:                
Interest   $ 3     $ 798  
Income Taxes   $ --     $ --  
                 
Non-cash investing and financing activities                
Common shares issued for extinguishment of debenture liability   $ --     $ 1,457  
Adjustment to opening retained earnings for the adoption of ASC 606   $ --     $ 1,287  
Deconsolidation of Sysorex as a result of spin-off   $ --     $ 11,838  
Common shares issued for extinguishment of liability   $ 1,130     $ --  
Common shares issued for extinguishment of debt   $ 3,114     $ --  
Right of use asset obtained in exchange for lease liability   $ 1,003     $ --  
Common shares issued for GTX acquisition   $ 650     $ --  
Common shares issued for Locality acquisition   $ 514     $ --  
Common shares issued for Jibestream acquisition   $ 862     $ --  

   

The accompanying notes are an integral part of these financial statements.

 

8

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 1 - Organization and Nature of Business and Going Concern

 

Inpixon, and its wholly-owned subsidiaries, Inpixon Canada, Inc. (“Inpixon Canada”) and Jibestream, Inc. (“Jibestream”), and its majority-owned subsidiary Inpixon India Limited (“Inpixon India”) (unless otherwise stated or the context otherwise requires, the terms “Inpixon” “we,” “us,” “our” and the “Company” refer collectively to Inpixon and the aforementioned subsidiaries), provide Big Data analytics and location based products and related services. The Company is headquartered in California, and has subsidiary offices in Coquitlam, Canada, Vancouver, Canada, Toronto, Canada and Hyderabad, India. India.

 

On August 31, 2018, the Company completed the spin-off of its value-added reseller business from its indoor positioning analytics business by way of a distribution of all the shares of common stock of its wholly-owned subsidiary, Sysorex, Inc. (“Sysorex”), to its stockholders of record as of August 21, 2018 and certain warrant holders. 

 

On May 21, 2019, the Company acquired Locality Systems Inc. (“Locality”), a technology company based near Vancouver, Canada, specializing in wireless device positioning and radio frequency augmentation of video surveillance systems (See Note 4). On June 27, 2019, the Company acquired certain global positioning system (“GPS”) products, software, technologies, and intellectual property from GTX Corp (“GTX”), a U.S. based company specializing in GPS technologies (See Note 5). These transactions expanded our patent portfolio and included certain granted or licensed patents and GPS and radio frequency (“RF”) technologies. Additionally, on August 15, 2019, the Company acquired Jibestream, a provider of indoor mapping and location technology based in Toronto, Canada (See Note 6).

 

Going Concern and Management’s Plans

 

As of September 30, 2019, the Company has a working capital deficiency of approximately $11.5 million. For the three and nine months ended September 30, 2019, the Company incurred a net loss of approximately $6.3 million and $16.7 million, respectively. The aforementioned factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of asset amounts or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern within one year after the date the financial statements are issued.

 

On January 15, 2019, the Company completed a rights offering whereby it sold 12,000 units at a price to the public of $1,000 per unit for aggregate net proceeds of approximately $10.77 million after commissions and expenses. On August 12, 2019, the Company completed a capital raise whereby the Company sold an aggregate of (i) 6,497,410 shares of our common stock, (ii) 2,997 shares of our Series 6 Convertible Preferred Stock, and (iii) Series A warrants to purchase up to an aggregate of 17,297,410 shares of common stock at an exercise price per share of $0.2775, resulting in net proceeds of approximately $4 million after deducting the underwriting discounts and offering expenses. The Company also raised approximately $3 million, $1.5 million, $1.5 million and $750,000 in net proceeds from the sale of promissory notes on May 3, 2019, June 26, 2019, August 8, 2019 and September 17, 2019, respectively.

 

The Company does not expect its capital resources as of September 30, 2019, availability on the Payplant facility to finance purchase orders and invoices in an amount equal to 80% of the face value of purchase orders received (as described in Note 7), and funds from revenue to be sufficient to fund planned operations for the next twelve months from the date the financial statements are issued.  In addition, the Company is pursuing possible strategic transactions and may raise such additional capital as needed, through the issuance of equity, equity-linked or debt securities.  In this regard, on October 10, 2019, the Company entered into an equity distribution agreement with Maxim Group LLC as its exclusive sales agent, under which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $6,500,000 from time to time.

 

The Company’s condensed consolidated financial statements as of September 30, 2019 have been prepared under the assumption that the Company will continue as a going concern for the next twelve months from the date the financial statements are issued. Management’s plans and assessment of the probability that such plans will mitigate and alleviate any substantial doubt about the Company’s ability to continue as a going concern is dependent upon the ability to attain further operating efficiency, reduce expenditures, and, ultimately, to generate sufficient levels of revenue. The Company’s condensed consolidated financial statements as of September 30, 2019 do not include any adjustments that might result from the outcome of this uncertainty. 

 

9

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 2 - Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles (“GAAP”), which are the accounting principles that are generally accepted in the United States of America. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of the Company’s operations for the nine-month period ended September 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019.  These interim unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes for the years ended December 31, 2018 and 2017 included in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 28, 2019. 

 

Note 3 - Summary of Significant Accounting Policies

 

The Company’s complete accounting policies are described in Note 2 to the Company’s audited consolidated financial statements and notes for the years ended December 31, 2018 and 2017.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during each of the reporting periods. Actual results could differ from those estimates. The Company’s significant estimates consist of:

 

  the valuation of stock-based compensation;
     
  the valuation of the assets and liabilities acquired of Locality, GTX and Jibestream as described in Notes 4, 5 and 6, respectively, as well as the valuation of the Company’s common shares issued in the transaction;
     
  the allowance for doubtful accounts;
     
  the valuation allowance for the deferred tax asset; and
     
  impairment of long-lived assets and goodwill.

 

Restricted Cash

 

In connection with certain transactions, the Company may be required to deposit assets, including cash or investment shares, in escrow accounts. The assets held in escrow are subject to various contingencies that may exist with respect to such transactions. Upon resolution of those contingencies or the expiration of the escrow period, some or all the escrow amounts may be used and the balance released to the Company. As of September 30, 2019, the Company had $71,000 deposited in escrow as restricted cash for the Shoom acquisition, of which any amounts not subject to claims shall be released to the pre-acquisition stockholders of Shoom, on a pro-rata basis, on the next anniversary date of the closing date of the Shoom acquisition which is current and included in Prepaid Assets and Other Current Assets on the condensed consolidated balance sheet. As of September 30, 2018, the Company had $140,000 deposited in escrow as restricted cash for the Shoom acquisition, of which any amounts not subject to claims would be released to the pre-acquisition stockholders of Shoom, on a pro-rata basis, on each of the next (2) anniversary dates of the closing date of the Shoom acquisition. $70,000 of that amount is current and included in Prepaid Assets and Other Current Assets and $70,000 is non-current and included in Other Assets on the condensed consolidated balance sheet as of September 30, 2018.

 

10

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 3 - Summary of Significant Accounting Policies (continued)

 

Restricted Cash (continued)

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the balance sheets that sum to the total of the same amounts shown in the statement of cash flows.

 

     For the
Nine Months Ended
September 30,
 
(in thousands)   2019     2018  
Cash and cash equivalents   $ 494     $ 1,461  
Restricted cash     71       70  
Restricted cash included in other assets, noncurrent     --       70  
Total cash, cash equivalents, and restricted cash in the balance sheet   $ 565     $ 1,601  

 

Revenue Recognition

 

The Company records revenue according to “Revenue from Contracts with Customers (Topic 606)”, or ASU 2016-12, which requires revenue to be recognized either at a “point in time” or “over time”, depending on the facts and circumstances of the arrangement, and is evaluated using a five-step model.

 

Software As A Service Revenue Recognition

 

With respect to sales of our maintenance, consulting and other service agreements, including our digital advertising and electronic services, customers pay fixed monthly fees in exchange for the Company’s service. The Company’s performance obligation is satisfied over time as the digital advertising and electronic services are provided continuously throughout the service period. The Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous access to its service. 

 

Professional Services Revenue Recognition

 

The Company’s professional services include fixed fee and time and materials contracts. Fixed fees are paid monthly, in phases, or upon acceptance of deliverables. The Company’s time and materials contracts are paid weekly or monthly based on hours worked. Revenue on time and materials contracts is recognized based on a fixed hourly rate as direct labor hours are expended. Materials, or other specified direct costs, are reimbursed as actual costs and may include markup. The Company has elected the practical expedient to recognize revenue for the right to invoice because the Company’s right to consideration corresponds directly with the value to the customer of the performance completed to date. For fixed fee contracts including maintenance service provided by in-house personnel, the Company recognizes revenue evenly over the service period using a time-based measure because the Company is providing continuous service. Because the Company’s contracts have an expected duration of one year or less, the Company has elected the practical expedient in Accounting Standards Codification (“ASC”) 606-10-50-14(a) to not disclose information about its remaining performance obligations. Anticipated losses are recognized as soon as they become known. For the three and nine months ended September 30, 2019 and 2018, the Company did not incur any such losses. These amounts are based on known and estimated factors.

 

11

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 3 - Summary of Significant Accounting Policies (continued)

 

Revenue Recognition (continued)

 

Contract Balances

 

The timing of our revenue recognition may differ from the timing of payment by our customers. The Company records a receivable when revenue is recognized prior to payment and the Company has an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenue until the performance obligations are satisfied. As of September 30, 2019, the Company had deferred revenue of approximately $789,000 related to software license agreements and approximately $262,000 related to cash received in advance for product maintenance services provided by the Company’s technical staff. The Company expects to satisfy its remaining performance obligations for these maintenance services and recognize the deferred revenue and related contract costs over the next twelve months after September 30, 2019.

 

Stock-Based Compensation

 

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date and recognized over the period services are required to be provided in exchange for the award, usually the vesting period. Forfeitures of unvested stock options are recorded when they occur.

 

The Company incurred stock-based compensation charges of $871,000 and $122,000 for the three months ended September 30, 2019 and 2018, respectively, and $2,618,000 and $979,000 for the nine months ended September 30, 2019 and 2018, respectively, which are included in general and administrative expenses. The Company recognizes forfeitures as they occur. The following table summarizes the nature of such charges for the periods then ended (in thousands):  

 

    For the
Three Months Ended
September 30,
    For the
Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
Compensation and related benefits   $ 871     $ 122     $ 2,376     $ 899  
Professional and legal fees     --       --       242       80  
Totals   $ 871     $ 122     $ 2,618     $ 979  

 

Net Loss Per Share

 

The Company computes basic and diluted earnings per share by dividing net loss by the weighted average number of common shares outstanding during the period. Basic and diluted net loss per common share were the same since the inclusion of common shares issuable pursuant to the exercise of options and warrants in the calculation of diluted net loss per common shares would have been anti-dilutive.

 

12

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 3 - Summary of Significant Accounting Policies (continued) 

 

Net Loss Per Share (continued)

 

The following table summarizes the number of common shares and common share equivalents excluded from the calculation of diluted net loss per common share for the nine months ended September 30, 2019 and 2018:

 

    For the
Nine Months Ended
September 30,
 
    2019     2018  
Options     5,584,423       67,454  
Warrants     7,319,040       1,622,971  
Convertible preferred stock     38,040       984  
Convertible note     --       15,881  
Reserved for service providers     1,100       1,100  
Common stock issuable pursuant to Jibestream acquisition share purchase agreement     2,864,000       --  
Totals     15,806,603       1,708,390  

 

Preferred Stock

 

The Company applies the accounting standards for distinguishing liabilities from equity under GAAP when determining the classification and measurement of its convertible preferred stock. Preferred shares subject to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable preferred shares (including preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred shares are classified as permanent equity.

 

Reclassification

 

Certain accounts in the prior year’s consolidated financial statements have been reclassified for comparative purposes to conform to the presentation in the current year’s consolidated financial statements. These reclassifications have no effect on previously reported earnings.

 

Recently Issued and Adopted Accounting Standards

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842),” (“ASU 2016-02”). ASU 2016-02 requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases. ASU 2016-02 will also require new qualitative and quantitative disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. As a result of the new standard, all of our leases greater than one year in duration are recognized in our balance sheets as both operating lease liabilities and right-of-use assets upon adoption of the standard. The Company adopted the standard using the modified-retrospective method effective January 1, 2019. This adoption primarily affected the Company’s condensed consolidated balance sheet based on the recording of right-of-use assets and the lease liability, current and noncurrent, for its operating leases. The adoption of ASU 2016-02 did not change the Company’s historical classification of these leases or the straight-line recognition of related expenses. Upon adoption, the Company recorded approximately $0.6 million in right-of-use assets and $0.7 million in operating lease liabilities on the Company’s balance sheet.

 

13

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 3 - Summary of Significant Accounting Policies (continued) 

 

Recently Issued and Adopted Accounting Standards (continued)

 

In June 2018, the FASB issued ASU No. 2018-07, “Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting,” (“ASU 2018-07”). ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 also clarifies that Topic 718 does not apply to share-based payments used to effectively provide (1) financing to the issuer or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Revenue from Contracts with Customers (Topic 606). ASU 2018-07 is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. The Company has adopted this standard and the adoption of this standard did not have a material impact on its financial statements or disclosures.

 

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement,” (“ASU 2018-13”). ASU 2018-13 requires application of the prospective method of transition (for only the most recent interim or annual period presented in the initial fiscal year of adoption) to the new disclosure requirements for (1) changes in unrealized gains and losses included in other comprehensive income and (2) the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU 2018-13 also requires prospective application to any modifications to disclosures made because of the change to the requirements for the narrative description of measurement uncertainty. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within that fiscal year.

 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 introduces a new forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including trade receivables. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. ASU 2016-13 also expands the disclosure requirements to enable users of financial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses. For public business entities that meet the definition of a Securities and Exchange Commission filer, ASU 2016-13 is effective for annual and interim reporting periods beginning after December 15, 2019, and the guidance is to be applied using the modified retrospective approach. Earlier adoption is permitted for annual and interim reporting periods beginning after December 15, 2018.

 

In April 2019, the FASB issued Accounting Standards Update No. 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (“ASU 2019-04”) and in May 2019, the FASB issued Accounting Standards Update No. 2019-05, Financial Instruments—Credit Losses (Topic 326) (“ASU 2019-05”). The Company is currently evaluating ASU 2016-13 and the related ASU 2019-04 and ASU 2019-05 to determine the impact to its condensed consolidated financial statements and related disclosures.

 

Subsequent Events

 

The Company evaluates events and/or transactions occurring after the balance sheet date and before the issue date of the condensed consolidated financial statements to determine if any of those events and/or transactions requires adjustment to or disclosure in the condensed consolidated financial statements. 

 

Note 4 - Locality Acquisition

 

On May 21, 2019, Inpixon, through its wholly owned subsidiary, Inpixon Canada as purchaser, completed its acquisition of Locality in which Locality’s stockholders sold all of their Locality Shares to the purchaser in exchange for consideration of (i) $1,500,000 (the “Aggregate Cash Consideration”) plus or minus the amount by which the estimated working capital is more or less than the working capital target (as defined in the purchase agreement), and (ii) 650,000 shares of common stock of Inpixon.

 

The Aggregate Cash Consideration, less the working capital adjustment to be applied against the Aggregate Cash Consideration of $85,923, will be paid in installments as follows: (i) the initial installment representing $250,000 minus $46,422 of the working capital adjustment was paid on the closing date; (ii) $210,499 on November 21, 2019 which is comprised of a $250,000 installment less $39,501 of the working capital adjustment; (iii) two additional installments, each equal to $250,000, will be paid twelve months and eighteen months after the closing date; and (iv) one final installment representing $500,000 will be paid on the second anniversary of the closing date, in each case minus the cash fees payable to the advisor in connection with the acquisition. Inpixon Canada will have the right to offset any loss, as defined in the purchase agreement, first, against any installment of the installment cash consideration that has not been paid and second, against the sellers and the advisor on a several basis, in accordance with the indemnification provisions of the purchase agreement.

 

14

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 4 - Locality Acquisition (continued)

 

The total recorded purchase price for the transaction was approximately $1,928,000, which consisted of cash at closing of $204,000, approximately $1,210,000 of cash that will be paid in installments as discussed above and $514,000 representing the value of the stock issued upon closing.

 

The preliminary purchase price is allocated as follows (in thousands):      
       
Assets Acquired:      
Cash   $ 70  
Accounts receivable     7  
Other current assets     4  
Inventory     2  
Fixed assets     1  
Developed technology     1,523  
Customer relationships     216  
Non-compete agreements     49  
Goodwill     619  
      2,491  
Liabilities Assumed:        
Accounts payable   $ 13  
Accrued liabilities     48  
Deferred revenue     28  
Deferred tax liability     474  
      563  
Total Purchase Price   $ 1,928  

  

Proforma information has not been presented as it has been deemed to be immaterial.

 

Note 5 - GTX Acquisition

 

On June 27, 2019, Inpixon completed its acquisition of certain assets of GTX, consisting of a portfolio of GPS technologies and intellectual property (the “Assets”).

 

The Assets were acquired for aggregate consideration consisting of (i) $250,000 in cash delivered at the closing and (ii) 1,000,000 shares of Inpixon’s restricted common stock of which 100,000 shares of common stock are subject to certain holdback restrictions and forfeiture for the purpose of satisfying indemnification claims.

 

The total recorded purchase price for the transaction was $900,000, which consisted of the cash paid of $250,000 and $650,000 representing the value of the stock issued upon closing.

 

Assets acquired (in thousands):      
       
Developed technology   $ 850  
Non-compete agreements     50  
         
Total Purchase Price   $ 900  

 

A final valuation of the assets and purchase price allocation of GTX has not been completed as of the end of this reporting period. Consequently, the purchase price was preliminarily allocated based upon our best estimates at the time of this filing. These amounts are subject to revision upon the completion of formal studies and valuations, as needed, which the Company expects to occur during the fourth quarter of 2019.

 

On September 16, 2019, the Company loaned GTX $50,000. The note accrues interest at a rate of 5% per annum and has a maturity date of April 13, 2020. Interest accrues beginning on the date that is the earlier of (i) 180 days from the issue date of the note and (ii) the registration effective date as defined in the acquisition agreement. This note is included as part of other receivables in the Company’s condensed consolidated financial statements. As of September 30, 2019, the balance of the note was $50,000.

 

15

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 6 - Jibestream Acquisition

 

On August 15, 2019, Inpixon, through its wholly owned subsidiary, Inpixon Canada as purchaser (the “Purchaser”), completed its acquisition of Jibestream for consideration consisting of: (i) CAD $5,000,000, plus an amount equal to all cash and cash equivalents held by Jibestream at the closing, minus, if a negative number, the absolute value of the Estimated Working Capital Adjustment (as defined in the acquisition agreement), minus any amounts loaned by the Purchaser to Jibestream to settle any Indebtedness (as defined in the Purchase Agreement) or other fees, minus any cash payments to the holders of outstanding options to settle any in-the-money options, minus the deferred revenue costs of CAD $150,000, and minus the costs associated with the audit and review of the financial statements of Jibestream required by the Purchase Agreement (collectively, the “Estimated Cash Closing Amount”); plus (ii) a number of shares of the Company’s common stock equal to CAD $3,000,000, which will be converted to U.S. dollars based on the exchange rate at the time of the closing, divided by $0.2775 which is the price per share at which shares of the Company’s common stock are issued in of the Company’s common stock the Offering on August 12, 2019 (“Inpixon Shares”).

 

The Nasdaq listing rules require the Company to obtain the approval of the Company’s stockholders for the issuance of 2,864,000 of the Inpixon Shares (the “Excess Shares”), which was obtained on October 31, 2019. A number of Inpixon Shares representing fifteen percent (15%) of the value of the Purchase Price (the “Holdback Amount”) will be subject to stop transfer restrictions and forfeiture to secure the indemnification and other obligations of the Vendors in favor of the Company arising out of or pursuant to Article VIII of the Purchase Agreement and, at the option of the Company, to secure the obligation of the Vendors’ to pay any adjustment to the Purchase Price pursuant to Section 2.5 of the Purchase Agreement. The Company has accrued an acquisition liability for the Excess Shares of approximately $490.000 which is included in the current liabilities section of the condensed consolidated balance sheet.

 

The total recorded purchase price for the transaction was approximately $5,062,000, which consisted of cash at closing of approximately $3,714,000 and $1,348,000 representing the value of the stock issued upon closing determined based on the closing price of the Company’s common stock as of the closing date on August 15, 2019. The purchase price is subject to adjustment for the Working Capital Adjustment as defined above.

 

The preliminary purchase price is allocated as follows (in thousands):

 

Assets Acquired:      
Cash   $ 6  
Accounts receivable     309  
Other current assets     137  
Fixed assets     10  
Other assets     430  
Developed technology     3,193  
Customer relationships     1,253  
Non-compete agreements     420  
Goodwill     2,407  
      8,165  
Liabilities Assumed:        
Accounts payable   $ 51  
Accrued liabilities     95  
Deferred revenue     1,156  
Other liabilities     512  
Deferred tax liability     1,289  
      3,103  
Total Purchase Price   $ 5,062  

 

A final valuation of the assets and purchase price allocation of Jibestream has not been completed as of the end of this reporting period. Consequently, the purchase price was preliminarily allocated based upon our best estimates at the time of this filing. These amounts are subject to revision upon the completion of formal studies and valuations, as needed, which the Company expects to occur during the fourth quarter of 2019.

 

16

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 7 - Proforma Financial Information

 

The following unaudited proforma financial information presents the consolidated results of operations of the Company and Jibestream for the three and nine months ended September 30, 2019 and 2018, as if the acquisition had occurred as of the beginning of the first period presented instead of on August 15, 2019. The proforma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during those periods.

 

(in thousands, except per share data)   For the Three Months Ended
September 30,
    For the Nine Months Ended
September 30,
 
    2019     2018     2019     2018  
Revenues   $ 1,777     $ 1,597     $ 5,644     $ 4,646  
Net loss attributable to common stockholders   $ (6,488 )   $ (5,734 )   $ (19,241 )   $ (29,934 )
Net loss per basic and diluted common share   $ (0.22 )   $ (0.45 )   $ (0.87 )   $ (2.48 )
Weighted average common shares outstanding:                                
Basic and Diluted     29,149,733       12,637,689       22,059,916       12,082,681  

 

Note 8 - Inventory

 

Inventory as of September 30, 2019 and December 31, 2018 consisted of the following (in thousands):

 

    As of
September 30,
2019
    As of
December 31,
2018
 
Raw materials   $ 179     $ 143  
Finished goods     585       425  
Total Inventory   $ 764     $ 568  

  

Note 9 - Debt

 

Debt as of September 30, 2019 and December 31, 2018 consisted of the following (in thousands):

 

    As of
September 30,
2019
   

As of
December 31,

2018

 
Short-Term Debt            
Notes payable, less debt discount of $1,118 and $752, respectively (A)   $ 9,800     $ 4,104  
Revolving line of credit (B)     259       23  
Total Short-Term Debt   $ 10,059     $ 4,127  
                 
Long-Term Debt                
Notes payable   $ --     $ 74  
Total Long-Term Debt   $ --     $ 74  

 

17

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 9 - Debt (continued)

 

(A) Notes Payable

 

On January 29, 2019, the Company and Chicago Venture Partners, L.P., the holder of that certain outstanding convertible promissory note ( “Chicago Venture” or the “Note Holder”), issued on November 17, 2017 (as amended, supplemented or otherwise modified, the “Original Note”), with an outstanding balance of $383,768 (the “Remaining Balance”), entered into an exchange agreement (the “Exchange Agreement”), pursuant to which the Company and the Note Holder agreed to (i) partition a new convertible promissory note in the form of the Original Note (the “Partitioned Note”) in the original principal amount equal to the Remaining Balance (the “Exchange Amount”) and then cause the Remaining Balance to be reduced by the Exchange Amount; and (ii) exchange the Partitioned Note for the delivery of 172,869 shares of the Company’s common stock at an effective price share equal to $2.22. Following such partition of the Original Note, the Original Note was deemed paid in full, was automatically deemed canceled, and shall not be reissued.

 

October 2018 Note Purchase Agreement and Promissory Note

 

On October 12, 2018, the Company entered into a note purchase agreement with Iliad Research and Trading, L.P. (the “Holder” or “Iliad”), which is affiliated with Chicago Venture, pursuant to which the Company agreed to issue and sell to the Holder an unsecured promissory note in an aggregate principal amount of $2,520,000, which is payable on or before the date that is 12 months from the issuance date. The initial principal amount includes an original issue discount of $500,000 and $20,000 that the Company agreed to pay to the Holder to cover the holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the note, the Holder paid an aggregate purchase price of $2,000,000. Interest on the note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the note. Beginning as of the date that was 6 months from the issuance date and at the intervals indicated below until the note is paid in full, the Holder has the right to redeem up to an aggregate of 1/3 of the initial principal balance of the note each month (each monthly exercise, a “Monthly Redemption Amount”) by providing written notice (each, a “Monthly Redemption Notice”) to the Company; provided, however, that if the Monthly Redemption Amount is not exercised in its corresponding month then such Monthly Redemption Amount will be available for the Holder to redeem in any future month in addition to such future month’s Monthly Redemption Amount. Upon receipt of any Monthly Redemption Notice, the Company is required to pay the applicable Monthly Redemption Amount in cash to the Holder within 5 business days of the Company’s receipt of such Monthly Redemption Notice.

 

During the nine months ended September 30, 2019, the Company exchanged $2,730,000 of the outstanding principal and interest under the note for 4,177,379 shares of the Company’s common stock at exchange prices between $0.51 and $0.8989 per share. The Company analyzed the exchange of principal under the note as an extinguishment and compared the net carrying value of the debt being extinguished to the reacquisition price (shares of common stock being issued) and recorded a $188,000 loss on the exchange of debt for equity as a separate item in the other income/expense section of the condensed consolidated statements of operations for the three and nine months ended September 30, 2019. These exchanges satisfied the liability in full and the balance owed under the note was $0 as of September 30, 2019.

 

18

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 9 - Debt (continued)

 

(A) Notes Payable (continued)

 

December 2018 Note Purchase Agreement and Promissory Note

 

On December 21, 2018, the Company entered into a note purchase agreement with Iliad, pursuant to which the Company agreed to issue and sell to Iliad an unsecured promissory note (the “December 2018 Note”) in an aggregate principal amount of $1,895,000, which is payable on or before December 31, 2019 (as provided in the Exchange Agreement, dated October 24, 2019, described below (the “October 24th Exchange Agreement”)). The initial principal amount includes an original issue discount of $375,000 and $20,000 that the Company agreed to pay to the Holder to cover its legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the December 2018 Note, the Holder paid an aggregate purchase price of $1,500,000. Interest on the Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the December 2018 Note. The Company may pay all or any portion of the amount owed earlier than it is due; provided, that in the event the Company elects to prepay all or any portion of the outstanding balance, it will pay 115% of the portion of the outstanding balance the Company elects to prepay. Beginning on the date that is 6 months from the issuance date and at the intervals indicated below until the December 2018 Note is paid in full, the Holder has the right to redeem up to an aggregate of 1/3 of the initial principal balance of the December 2018 Note each month (each monthly exercise, a “Monthly Redemption Amount”) by providing written notice (each, a “Monthly Redemption Notice”) delivered to the Company; provided, however, that if any Monthly Redemption Amount is not exercised in its corresponding month then such Monthly Redemption Amount will be available for the Holder to redeem in any future month in addition to such future month’s Monthly Redemption Amount. Upon receipt of any Monthly Redemption Notice, the Company shall pay the applicable Monthly Redemption Amount in cash within 5 business days of the Company’s receipt of such Monthly Redemption Notice. Pursuant to the October 24th Exchange Agreement described below, the Holder agreed that the exercise of any redemption rights described above would be deferred until no earlier than December 31, 2019.

 

Amendment to Note Purchase Agreements

 

On February 8, 2019, the Company entered into a global amendment (the “Global Amendment”) to the note purchase agreements entered into on October 12, 2018 and December 21, 2018, in connection with the notes issued as of such dates, to delete the phrase “by cancellation or exchange of the Note, in whole or in part” from Section 8.1 of those agreements. The Company also agreed to pay Iliad’s fees and other expenses in an aggregate amount of $80,000 (the “Fee”) in connection with the preparation of the Global Amendment by adding $40,000 of the Fee to the outstanding balance of each of the notes.

 

Standstill Agreement

 

On August 8, 2019, the Company and Iliad entered into a standstill agreement with respect to the December 2018 Note (the “Standstill Agreement”). Pursuant to the Standstill Agreement, Iliad agreed that it will not redeem all or any portion of the December 2018 Note for a period beginning on August 8, 2019, and ending on the date that is 90 days from August 8, 2019. As consideration for this, the outstanding balance of the December 2018 Note was increased by $206,149.

 

19

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 9 - Debt (continued)

 

(A) Notes Payable (continued)

 

May 2019 Note Purchase Agreement and Promissory Note

 

On May 3, 2019, the Company entered into a note purchase agreement (the “Purchase Agreement”) with Chicago Venture, pursuant to which the Company agreed to issue and sell to the investor an unsecured promissory note (the “May 2019 Note”) in an aggregate principal amount of $3,770,000, which is payable on or before the date that is 10 months from the issuance date. The initial principal amount includes an original issue discount of $750,000 and $20,000 that the Company agreed to pay to the holder to cover the holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the May 2019 Note, the holder paid an aggregate purchase price of $3,000,000. Interest on the May 2019 Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the May 2019 Note. The Company may pay all or any portion of the amount owed earlier than it is due; provided, that in the event the Company elects to prepay all or any portion of the outstanding balance, it shall pay to the holder 115% of the portion of the outstanding balance the Company elects to prepay. Beginning on the date that is 6 months from the issuance date and at the intervals indicated below until the May 2019 Note is paid in full, the holder shall have the right to redeem up to an aggregate of 1/3 of the initial principal balance of the May 2019 Note each month (each monthly exercise, a “Monthly Redemption Amount”) by providing written notice (each, a “Monthly Redemption Notice”) delivered to the Company; provided, however, that if the holder does not exercise any Monthly Redemption Amount in its corresponding month then such Monthly Redemption Amount shall be available for the holder to redeem in any future month in addition to such future month’s Monthly Redemption Amount. Upon receipt of any Monthly Redemption Notice, the Company shall pay the applicable Monthly Redemption Amount in cash to the holder within five business days of the Company’s receipt of such Monthly Redemption Notice.

 

June 2019 Note Purchase Agreement and Promissory Note

 

On June 27, 2019, the Company entered into a note purchase agreement (the “Purchase Agreement”) with Chicago Venture, pursuant to which the Company agreed to issue and sell to the holder an unsecured promissory note (the “June 2019 Note”) in an aggregate principal amount of $1,895,000, which is payable on or before the date that is 9 months from the issuance date. The initial principal amount includes an original issue discount of $375,000 and $20,000 that the Company agreed to pay to the holder to cover the holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the June 2019 Note, the holder paid an aggregate purchase price of $1,500,000. Interest on the June 2019 Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the June 2019 Note. The Company may pay all or any portion of the amount owed earlier than it is due; provided, that in the event the Company elects to prepay all or any portion of the outstanding balance, it shall pay to the holder 115% of the portion of the outstanding balance the Company elects to prepay. Beginning on the date that is 6 months from the issuance date and at the intervals indicated below until the June 2019 Note is paid in full, the holder shall have the right to redeem up to an aggregate of 1/3 of the initial principal balance of the June 2019 Note each month by providing written notice delivered to the Company; provided, however, that if the holder does not exercise any monthly redemption amount in its corresponding month then such monthly redemption amount shall be available for the holder to redeem in any future month in addition to such future month’s monthly redemption amount. Upon receipt of any monthly redemption notice, the Company shall pay the applicable monthly redemption amount in cash to the holder within five business days. The June 2019 Note includes customary event of default provisions, subject to certain cure periods, and provides for a default interest rate of 22%. Upon the occurrence of an event of default (except a default due to the occurrence of bankruptcy or insolvency proceedings (the “Bankruptcy-Related Event of Default”)), the holder may, by written notice, declare all unpaid principal, plus all accrued interest and other amounts due under the June 2019 Note to be immediately due and payable at an amount equal to 115% of the outstanding balance of the June 2019 Note (the “Mandatory Default Amount”). Upon the occurrence of a Bankruptcy-Related Event of Default, without notice, all unpaid principal, plus all accrued interest and other amounts due under the June 2019 Note will become immediately due and payable at the Mandatory Default Amount. Pursuant to the terms of the Purchase Agreement, if at any time while the June 2019 Note is outstanding, the Company will immediately following the completion of any offering of its equity securities make a cash payment to the holder in the following amount: (a) twenty-five percent (25%) of the outstanding balance of the June 2019 Note if the Company receives net proceeds equal to $2,500,000.00 or less; (b) fifty percent (50%) of the outstanding balance of the June 2019 Note if the Company receives net proceeds of more than $2,500,000.00 but less than $5,000,000.00; and (c) one hundred percent (100%) of the outstanding balance of the June 2019 Note if the Company receives net proceeds equal to $5,000,000.00 or more.

 

20

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 9 - Debt (continued)

 

(A) Notes Payable (continued)

 

Effective as of August 12, 2019, the Company and Chicago Venture entered into an amendment agreement, dated as of August 14, 2019, to provide that the Company’s obligation to repay all or a portion of the outstanding balance of the June 2019 Note upon the completion of any offering of equity securities of the Company would not apply or be effective until December 27, 2019. As consideration for the amendment, a fee of $191,883 was added to the outstanding balance of the June 2019 Note.

 

August 2019 Note Purchase Agreement and Promissory Note

 

On August 8, 2019, the Company entered into a note purchase agreement with Chicago Venture, pursuant to which the Company agreed to issue and sell to the holder an unsecured promissory note (the “August 2019 Note”) in an aggregate principal amount of $1,895,000, which is payable on or before the date that is 9 months from the issuance date. The Initial Principal Amount includes an original issue discount of $375,000 and $20,000 that the Company agreed to pay to the holder to cover the holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the August 2019 Note, the holder paid an aggregate purchase price of $1,500,000. Interest on the Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the August 2019 Note. The Company may pay all or any portion of the amount owed earlier than it is due; provided, that in the event the Company elects to prepay all or any portion of the outstanding balance, it shall pay to the Holder 115% of the portion of the outstanding balance the Company elects to prepay. Beginning on the date that is 6 months from the issuance date and at the intervals indicated below until the August 2019 Note is paid in full, the holder shall have the right to redeem up to an aggregate of 1/3 of the initial principal balance of the August 2019 Note each month by providing written notice to the Company; provided, however, that if the holder does not exercise any monthly redemption amount in its corresponding month then such monthly redemption amount shall be available for the holder to redeem in any future month in addition to such future month’s monthly redemption amount. Upon receipt of any monthly redemption notice, the Company shall pay the applicable monthly redemption amount in cash to the holder within five business days of the Company’s receipt of such monthly redemption notice. The August 2019 Note includes customary event of default provisions, subject to certain cure periods, and provides for a default interest rate of 22%. Upon the occurrence of an event of default (except a default due to the occurrence of bankruptcy or insolvency proceedings (the “Bankruptcy-Related Event of Default”)), the Holder may, by written notice, declare all unpaid principal, plus all accrued interest and other amounts due under the August 2019 Note to be immediately due and payable at an amount equal to 115% of the outstanding balance of the Note (the “Mandatory Default Amount”). Upon the occurrence of a Bankruptcy-Related Event of Default, without notice, all unpaid principal, plus all accrued interest and other amounts due under the Note will become immediately due and payable at the Mandatory Default Amount.

 

21

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 9 - Debt (continued)

 

(A) Notes Payable (continued)

 

September 2019 Note Purchase Agreement and Promissory Note

 

On September 17, 2019, the Company entered into a note purchase agreement with Iliad, pursuant to which the Company agreed to issue and sell to the Holder an unsecured promissory note (the “September 2019 Note”) in an aggregate principal amount of $952,500.00, which is payable on or before the date that is 9 months from the issuance date. The Initial Principal Amount includes an original issue discount of $187,500 and $15,000 that the Company agreed to pay to the Holder to cover the Holder’s legal fees, accounting costs, due diligence, monitoring and other transaction costs. In exchange for the Note, the Holder paid an aggregate purchase price of $750,000.00. Interest on the Note accrues at a rate of 10% per annum and is payable on the maturity date or otherwise in accordance with the September 2019 Note. The Company may pay all or any portion of the amount owed earlier than it is due; provided, that in the event the Company elects to prepay all or any portion of the outstanding balance, it shall pay to the Holder 115% of the portion of the outstanding balance the Company elects to prepay. Beginning on the date that is 6 months from the issuance date and at the intervals indicated below until the September 2019 Note is paid in full, the holder shall have the right to redeem up to an aggregate of 1/3 of the initial principal balance of the September 2019 Note each month by providing written notice to the Company; provided, however, that if the holder does not exercise any monthly redemption amount in its corresponding month then such monthly redemption amount shall be available for the holder to redeem in any future month in addition to such future month’s monthly redemption amount. Upon receipt of any monthly redemption notice, the Company shall pay the applicable monthly redemption amount in cash to the holder within five business days of the Company’s receipt of such monthly redemption notice. The September 2019 Note includes customary event of default provisions, subject to certain cure periods, and provides for a default interest rate of 22%. Upon the occurrence of an event of default (except a default due to the occurrence of bankruptcy or insolvency proceedings (the “Bankruptcy-Related Event of Default”)), the Holder may, by written notice, declare all unpaid principal, plus all accrued interest and other amounts due under the September 2019 Note to be immediately due and payable at an amount equal to 115% of the outstanding balance of the Note (the “Mandatory Default Amount”). Upon the occurrence of a Bankruptcy-Related Event of Default, without notice, all unpaid principal, plus all accrued interest and other amounts due under the Note will become immediately due and payable at the Mandatory Default Amount.

 

(B) Revolving Line of Credit

 

In accordance with the Payplant Loan and Security Agreement, dated as of August 14, 2017 (the “Loan Agreement”), the Loan Agreement allows the Company to request loans from the Lender (in the manner provided therein) with a term of no greater than 360 days in amounts that are equivalent to 80% of the face value of purchase orders received. The Lender is not obligated to make the requested loan, however, if the Lender agrees to make the requested loan, before the loan is made, the Company must provide Lender with (i) one or more promissory notes for the amount being loaned in favor of Lender, (ii) one or more guaranties executed in favor of Lender and (iii) other documents and evidence of the completion of such other matters as Lender may request. The principal amount of each loan shall accrue interest at a 30 day rate of 2% (the “Interest Rate”), calculated per day on the basis of a year of 360 days and, when combined with all fees that may be characterized as interest will not exceed the maximum rate allowed by law. Upon the occurrence and during the continuance of any event of default, interest shall accrue at a rate equal to the Interest Rate plus 0.42% per 30 days. All computations of interest shall be made on the basis of a year of 360 days. The promissory note is subject to the interest rates described in the Loan Agreement and is secured by the assets of the Company pursuant to the Loan Agreement and will be satisfied in accordance with the terms of the Payplant Client Agreement.

 

On August 31, 2018, Inpixon, Sysorex, SGS, and Payplant executed Amendment 1 to Payplant Client Agreement (the “Amendment”). Pursuant to the Amendment, Sysorex and SGS are no longer parties to the Payplant Client Agreement, originally entered into on August 14, 2017, and have been released from any and all obligations and liabilities arising under the Payplant Client Agreement, whether such obligations and liabilities were in existence prior to or on the date of the Amendment or arise after the date of the Amendment.

 

22

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 10 - Capital Raises

 

January 2019 Capital Raise

 

On January 15, 2019, the Company closed a rights offering whereby it sold an aggregate of 12,000 units consisting of an aggregate of 12,000 shares of Series 5 Convertible Preferred Stock and 3,600,000 warrants to purchase common stock exercisable for one share of common stock at an exercise price of $3.33 per share in accordance with the terms and conditions of a warrant agency agreement, resulting in gross proceeds to the Company of approximately $12 million, and net proceeds of approximately $10.77 million after deducting expenses relating to dealer-manager fees and expenses, and excluding any proceeds received upon exercise of any warrants.

 

Following the rights offering, the conversion price of the Series 4 Convertible Preferred Stock was reduced to the floor price of $4.96, the exercise price of the warrants issued in the April 2018 public offering were also reduced to the floor price of $4.96 and the number of shares issuable upon exercise of such warrants was increased to 2,769,000 shares of common stock. The maximum deemed dividend under the Series 4 Convertible Preferred Stock has been recognized so there is no accounting effect from the conversion price reduction of the Series 4 Convertible Preferred Stock. However, the Company recorded a $1.3 million deemed dividend for the reduction to the exercise price of the April 2018 warrants.

 

August 2019 Financing

 

On August 12, 2019, the Company sold an aggregate of (i) 6,497,410 shares of our common stock, (ii) 2,997 shares of our Series 6 Convertible Preferred Stock, with a stated value $1,000 per share, convertible into shares of our common stock (the “Series 6 Preferred Stock”), and (iii) Series A warrants to purchase up to an aggregate of 17,297,410 shares of common stock at an exercise price per share of $0.2775, resulting in gross proceeds to the Company of approximately $4.8 million, and net proceeds of approximately $4 million after deducting the underwriting discounts and offering expenses.

 

Note 11 - Common Stock

 

On January 29, 2019, the Company issued 172,869 shares of common stock under an exchange agreement to settle the outstanding balance of $383,768 under a partitioned note. (see Note 9)

 

On February 20, 2019, the Company issued 749,440 shares of common stock under a settlement agreement for an arbitration proceeding (see Note 18).

 

During the three months ended March 31, 2019, the Company issued 13,761 shares of common stock in connection with the exercise of 13,761 warrants at $3.33 per share.

 

During the three months ended March 31, 2019, the Company issued 1,248,324 shares of common stock in connection with the exercise of 2,080,539 warrants through cashless exercises.

 

During the three months ended March 31, 2019, 10,062 shares of Series 5 Convertible Preferred Stock were converted into 3,021,663 shares of the Company’s common stock.

 

During the three months ended March 31, 2019, the Company issued 200,000 shares of common stock for services which were fully vested upon grant. The Company recorded an expense of approximately $242,000.

 

During the three months ended June 30, 2019, the Company issued 2,773,607 shares of common stock under an exchange agreement to settle the outstanding balance of $2,005,000 under a partitioned note (See Note 9).

 

During the three months ended June 30, 2019, the Company issued 835,740 shares of common stock in connection with the exercise of 1,392,900 warrants through cashless exercises.

 

23

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 11 - Common Stock (continued)

 

During the three months ended June 30, 2019, 1,812 shares of Series 5 Convertible Preferred Stock were converted into 544,145 shares of the Company’s common stock.

 

On May 21, 2019, the Company issued 650,000 shares of common stock to Locality as part of an acquisition (See Note 4).

 

On June 27, 2019, the Company issued 1,000,000 shares of common stock to GTX as part of an acquisition (See Note 5).

 

On August 12, 2019 the Company issued 6,497,410 shares of common stock as part of a public offering (See Note 10).

 

On August 15, 2019, the Company issued 5,068,969 shares of common stock to security holders of Jibestream as part of an acquisition (See Note 6).

 

During the three months ended September 30, 2019, the Company issued 1,403,772 shares of common stock under an exchange agreement to settle the outstanding balance of approximately $725,000 under a partitioned note (See Note 9).

 

During the three months ended September 30, 2019, the Company issued 13,956,909 shares of common stock in connection with the exercise of 13,956,909 warrants through cashless exercises.

 

During the three months ended September 30, 2019, 2,997 shares of Series 6 Convertible Preferred Stock were converted into 10,800,011 shares of the Company’s common stock.

 

Note 12 - Preferred Stock

 

The Company is authorized to issue up to 5,000,000 shares of preferred stock with a par value of $0.001 per share with rights, preferences, privileges and restrictions as to be determined by the Company’s Board of Directors.

 

Series 5 Convertible Preferred Stock

 

On January 14, 2019, the Company filed with the Secretary of State of the State of Nevada the Certificate of Designation that created the Series 5 Convertible Preferred Stock, authorized 12,000 shares of Series 5 Convertible Preferred Stock and designated the preferences, rights and limitations of the Series 5 Convertible Preferred Stock. The Series 5 Convertible Preferred Stock is non-voting (except to the extent required by law). The Series 5 Convertible Preferred Stock is convertible into the number of shares of Common Stock, determined by dividing the aggregate stated value of the Series 5 Convertible Preferred Stock of $1,000 per share to be converted by $3.33.

 

On January 15, 2019, the Company closed a rights offering whereby it sold an aggregate of 12,000 units consisting of an aggregate of 12,000 shares of Series 5 Convertible Preferred Stock and 3,600,000 warrants to purchase common stock exercisable for one share of common stock at an exercise price of $3.33 per share.

 

During the three months ended March 31, 2019, 10,062 shares of Series 5 Convertible Preferred Stock were converted into 3,021,663 shares of the Company’s common stock.

 

During the three months ended June 30, 2019, 1,812 shares of Series 5 Convertible Preferred Stock were converted into 544,145 shares of the Company’s common stock.

 

As of September 30, 2019, there were 126 shares of Series 5 Convertible Preferred Stock outstanding.

 

24

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 12 - Preferred Stock (continued)

 

Series 6 Convertible Preferred Stock

 

On August 13, 2019, the Company filed the  Certificate of Designation of Preferences, Rights and Limitations of Series 6 Convertible Preferred Stock (the “Series 6 Preferred Certificate of Designation”) with the Secretary of State of Nevada, establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series 6 Convertible Preferred Stock with a stated value of $1,000 and convertible into a number of shares of the Company’s common stock equal to $1,000 divided by $0.2775.

 

 On August 12, 2019, the Company closed a public offering whereby it sold an aggregate of 2,997 shares of Series 6 Convertible Preferred Stock, 6,497,410 shares of our common stock and 17,297,410 warrants to purchase common stock exercisable for one share of common stock at an exercise price of $0.2775 per share.

 

During the three months ended September 30, 2019, 2,997 shares of Series 6 Convertible Preferred Stock were converted into 10,800,011 shares of the Company’s common stock.

 

As of September 30, 2019, there were 0 shares of Series 6 Convertible Preferred Stock outstanding.

 

Note 13 - Stock Options

 

In September 2011, the Company adopted the 2011 Employee Stock Incentive Plan (the “2011 Plan”) which provides for the granting of incentive and non-statutory common stock options and stock based incentive awards to employees, non-employee directors, consultants and independent contractors. The 2011 Plan was amended and restated in May 2014. Unless terminated sooner by the Board of Directors, this plan will terminate on August 31, 2021.

 

In February 2018, the Company adopted the 2018 Employee Stock Incentive Plan (the “2018 Plan” and together with the 2011 Plan, the “Option Plans”), which is utilized with the 2011 Plan for employees, corporate officers, directors, consultants and other key persons employed. The 2018 Plan provides for the granting of incentive stock options, NQSOs, stock grants and other stock-based awards, including Restricted Stock and Restricted Stock Units (as defined in the 2018 Plan).

  

Incentive stock options granted under the Option Plans are granted at exercise prices not less than 100% of the estimated fair market value of the underlying common stock at date of grant. The exercise price per share for incentive stock options may not be less than 110% of the estimated fair value of the underlying common stock on the grant date for any individual possessing more that 10% of the total outstanding common stock of the Company. Options granted under the Option Plans vest over periods ranging from immediately to four years and are exercisable over periods not exceeding ten years.

 

The aggregate number of shares that may be awarded under the 2011 Plan as of September 30, 2019 is 158,424 and awarded under the 2018 Plan as of September 30, 2019 is 7,316,376. As of September 30, 2019, 5,584,423 of options were granted to employees, directors and consultants of the Company (including 39 shares outside of our Options Plans) and 1,890,416 shares of common stock were reserved for future issuance under the Option Plans.

 

During the three months ended March 31, 2019, the Company granted stock options for the purchase of 2,717,500 shares of common stock to employees and directors of the Company. These stock options are either 100% vested or vest pro-rata over 12 to 48 months, have a life of ten years and an exercise price of $2.26 per share. The Company valued the stock options using the Black-Scholes option valuation model and the fair value of the awards was determined to be $3.3 million. The fair value of the common stock as of the grant date was determined to be $2.26 per share.

 

25

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 13 - Stock Options (continued)

 

During the three months ended June 30, 2019, the Company granted stock options for the purchase of 2,337,500 shares of common stock to employees and directors of the Company. These stock options vest pro-rata over 12 to 48 months, have a life of ten years and an exercise price of $0.75 per share. The Company valued the stock options using the Black-Scholes option valuation model and the fair value of the awards was determined to be $928,000. The fair value of the common stock as of the grant date was determined to be $0.75 per share.

 

During the three months ended September 30, 2019, the Company granted stock options for the purchase of 819,500 shares of common stock to employees and directors of the Company. These stock options vest pro-rata over 12 to 48 months, have a life of ten years and an exercise price of $0.47 per share. The Company valued the stock options using the Black-Scholes option valuation model and the fair value of the awards was determined to be approximately $145,000. The fair value of the common stock as of the grant date was determined to be $0.47 per share.

 

The Company recorded a stock based compensation charge for the amortization of employee stock options of $871,000 and $122,000 for the three months ended September 30, 2019 and 2018, respectively, and $2,376,000 and $899,000, for the nine months ended September 30, 2019 and 2018, respectively.

 

As of September 30, 2019, the fair value of non-vested stock options totaled $1.9 million, which will be amortized to expense over the weighted average remaining term of 0.68 years.

 

The fair value of each employee stock option grant is estimated on the date of the grant using the Black-Scholes option-pricing model. Key weighted-average assumptions used to apply this pricing model during the nine months ended September 30, 2019 were as follows:

 

    For the
Nine Months Ended
September 30,
2019
     
Risk-free interest rate   1.77-2.66%
Expected life of stock option grants   7 years
Expected volatility of underlying stock   49.48-106.16%
Dividends assumption   $--

 

The expected stock price volatility for the Company’s stock options was determined by the historical volatilities for industry peers and used an average of those volatilities. The Company attributes the value of stock-based compensation to operations on the straight-line single option method. Risk free interest rates were obtained from U.S. Treasury rates for the applicable periods. The dividends assumption was $0 as the Company historically has not declared and does not expect to declare any dividends.

 

26

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 14 - Credit Risk and Concentrations

 

Financial instruments that subject the Company to credit risk consist principally of trade accounts receivable and cash and cash equivalents. The Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk. The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk of its customers, establishes an allowance for uncollectible accounts and, consequently, believes that its accounts receivable credit risk exposure beyond such allowances is limited.

 

The Company maintains cash deposits with financial institutions, which, from time to time, may exceed federally insured limits. Cash is also maintained at foreign financial institutions for its Canadian subsidiary and its majority-owned India subsidiary. Cash in foreign financial institutions as of September 30, 2019 and December 31, 2018 was immaterial. The Company has not experienced any losses and believes it is not exposed to any significant credit risk from cash.

  

The following table sets forth the percentages of revenue derived by the Company from those customers which accounted for at least 10% of revenues during the nine months ended September 30, 2019 and 2018 (in thousands):

 

    For the
Nine Months Ended
September 30,
2019
 

For the

Nine Months Ended

September 30,
2018

    $   %   $   %
Customer A   2,000   46%   --   --
Customer B   918   21%   956   36%
Customer C   --   --   280   11%

 

The following table sets forth the percentages of revenue derived by the Company from those customers which accounted for at least 10% of revenues during the three months ended September 30, 2019 and 2018 (in thousands):

 

    For the
Three Months Ended
September 30,
2019
 

For the

Three Months Ended

September 30,
2018

    $   %   $   %
Customer A   500   33%   --   --
Customer B   306   20%   311   33%

  

As of September 30, 2019, Customer A represented approximately 59%, Customer B represented approximately 0%, and Customer C represented approximately 0% of total accounts receivable. As of September 30, 2018, Customer A represented approximately 0%, Customer B represented approximately 5%, and Customer C represented approximately 24% of total accounts receivable. 

 

As of September 30, 2019, two vendors represented approximately 41% and 14% of total gross accounts payable. There were no purchases from these vendors during the three and nine months ended September 30, 2019.  As of September 30, 2018, one vendor represented approximately 60% of total gross accounts payable. There were no purchases from this vendor during the three and nine months ended September 30, 2018.

 

27

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 15 - Foreign Operations

 

The Company’s operations are located primarily in the United States, Canada, and India. Revenues by geographic area are attributed by country of domicile of our subsidiaries. The financial data by geographic area are as follows (in thousands):

 

    United                          
    States     Canada     India     Eliminations     Total  
For the Three Months Ended September 30, 2019:                              
Revenues by geographic area   $ 1,231     $ 303     $ 154     $ (154 )   $ 1,534  
Operating income (loss) by geographic area   $ (4,733 )   $ (977 )   $ 26     $ --     $ (5,684 )
Net income (loss) by geographic area   $ (5,658 )   $ (947 )   $ 26     $ --     $ (6,579 )
                                         
For the Three Months Ended September 30, 2018:                                        
Revenues by geographic area   $ 930     $ 10     $ 76     $ (76 )   $ 940  
Operating income (loss) by geographic area   $ (3,022 )   $ (317 )   $ 22     $ --     $ (3,317 )
Net income (loss) by geographic area   $ (4,885 )   $ (317 )   $ 22     $ --     $ (5,180 )
                                         
For the Nine Months Ended September 30, 2019:                                        
Revenues by geographic area   $ 4,064     $ 323     $ 391     $ (391 )   $ 4,387  
Operating income (loss) by geographic area   $ (13,433 )   $ (1,889 )   $ 50     $ --     $ (15,272 )
Net income (loss) by geographic area   $ (14,903 )   $ (1,857 )   $ 50     $ --     $ (16,710 )
                                         
For the Nine Months Ended September 30, 2018:                                        
Revenues by geographic area   $ 2,606     $ 21     $ 202     $ (202 )   $ 2,627  
Operating income (loss) by geographic area   $ (10,422 )   $ (1,192 )   $ 35     $ --     $ (11,579 )
Net income (loss) by geographic area   $ (16,117 )   $ (1,196 )   $ 35     $ --     $ (17,278 )
                                         
As of September 30, 2019:                                        
Identifiable assets by geographic area   $

19,523

    $

10,788

    $ 180     $ --     $ 30,491  
Long lived assets by geographic area   $ 4,456     $ 6,548     $ 39     $ --     $ 11,043  
                                         
As of December 31, 2018:                                        
Identifiable assets by geographic area   $ 11,872     $ 187     $ 119     $ --     $ 12,178  
Long lived assets by geographic area   $ 6,233     $ 140     $ 28     $ --     $ 6,401  

  

28

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 16 - Related Party Transactions

 

Nadir Ali, the Company’s Chief Executive Officer and a member of its Board of Directors, is also the Chairman of the Board of Directors of Sysorex.

 

Sysorex Note Purchase Agreement

 

On December 31, 2018, the Company and Sysorex entered into a note purchase agreement (the “Note Purchase Agreement”) pursuant to which the Company agreed to purchase from Sysorex at a purchase price equal to the Loan Amount (as defined below), a secured promissory note (the “Secured Note”) for up to an aggregate principal amount of $3 million (the “Principal Amount”), including any amounts advanced through the date of the Secured Note (the “Prior Advances”), to be borrowed and disbursed in increments (such borrowed amount, together with the Prior Advances, collectively referred to as the “Loan Amount”), with interest to accrue at a rate of 10% percent per annum on all such Loan Amounts, beginning as of the date of disbursement with respect to any portion of such Loan Amount. In addition, Sysorex agreed to pay $20,000 to the Company to cover the Company’s legal fees, accounting costs, due diligence, monitoring and other transaction costs incurred in connection with the purchase and sale of the Secured Note (the “Transaction Expense Amount”), all of which amount is included in the Principal Amount. Sysorex may borrow repay and borrow under the Secured Note, as needed, for a total outstanding balance, exclusive of any unpaid accrued interest, not to exceed the Principal Amount at any one time.

 

All sums advanced by the Company to the Maturity Date (as defined below) pursuant to the terms of the Note Purchase Agreement will become part of the aggregate Loan Amount underlying the Secured Note. All outstanding principal amounts and accrued unpaid interest owing under the Secured Note shall become immediately due and payable on the earlier to occur of (i) 24 month anniversary of the date the Secured Note is issued (the “Maturity Date”), (ii) at such date when declared due and payable by the Company upon the occurrence of an Event of Default (as defined in the Secured Note), or (iii) at any such earlier date as set forth in the Secured Note. All accrued unpaid interest shall be payable in cash. The amount owed for principal and accrued interest by Sysorex to the Company as of December 31, 2018 was $2.2 million and as of September 30, 2019 was approximately $10.4 million. On February 4, 2019, the Related Party Note was amended to increase the maximum principal amount that may be outstanding at any time under the Related Party Note from $3 million to $5 million. On April 2, 2019, the Related Party Note was amended to increase the maximum principal amount that may be outstanding at any time under the Related Party Note from $5 million to $8 million. On May 22, 2019, the Related Party Note was amended to increase the maximum principal amount that may be outstanding at any time under the Related Party Note from $8 million to $10 million.

 

Jibestream Promissory Note

 

On August 12, 2019, prior to the acquisition of Jibestream, the Company loaned Jibestream $140,600 for operating expenses. The note accrues interest at a rate of 5% per annum and has a maturity date of December 31, 2019. This note is recorded as a current note receivable on the Company books, however, it is eliminated in the condensed consolidated financial statements. As of September 30, 2019, the balance of the note including principal and interest was approximately $142,000.

 

Note 17 - Leases

 

The Company has an operating lease is for its administrative office in Palo Alto, California, effective October 1, 2014, for five years.  The initial lease rate was $14,225 per month with escalating payments.  In connection with the lease, the Company is obligated to pay $8,985 monthly for operating expenses for building repairs and maintenance.  The Company also has an operating lease is for its administrative office in Encino, CA. This lease was effective June 1, 2014 and will end on July 31, 2021. The current lease rate is $6,984 per month and $276 per month for the common area maintenance. Additionally, the Company has an operating lease is for its administrative office in Coquitlam, Canada, from October 1, 2016 through September 30, 2021. The initial lease rate was $8,931 CAD per month with escalating payments.  In connection with the lease, the Company is obligated to pay $6,411 CAD monthly for operating expenses for building repairs and maintenance.  The Company has an operating lease is for its administrative office in Toronto, Canada, from August 15, 2019 through May 31, 2021. The monthly lease rate is $24,503 CAD per month with no escalating payments.  In connection with the lease, the Company is obligated to pay $9,651 CAD monthly for operating expenses for building repairs and maintenance.  The Company has no other operating or financing leases with terms greater than 12 months.

 

29

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 17 - Leases (continued)

 

The Company adopted ASC Topic 842, Leases (“ASC Topic 842”) effective January 1, 2019 using the modified-retrospective method, and thus, the prior comparative period continues to be reported under the accounting standards in effect for that period.

 

The Company elected to use the package of practical expedients permitted which allows (i) an entity not to reassess whether any expired or existing contracts are or contain leases; (ii) an entity need not reassess the lease classification for any expired or existing leases; and (iii) an entity need not reassess any initial direct costs for any existing leases. At the time of adoption, the Company did not have any leases with terms of 12 months or less, which would have resulted in short-term lease payments being recognized in the condensed consolidated statements of income on a straight-line basis over the lease term. All of the Company’s leases were previously classified as operating and are similarly classified as operating lease under the new standard.

 

On January 1, 2019, upon adoption of ASC Topic 842, the Company recorded right-of-use asset of $641,992, lease liability of $683,575 and eliminated deferred rent of $41,583. The adoption of ASC 842 did not have a material impact to prior year comparative periods and a result, a cumulative-effect adjustment was not required. The Company determined the lease liability using the Company’s estimated incremental borrowing rate of 8.0% to estimate the present value of the remaining monthly lease payments. With the Jibestream acquisition, the Company adopted ASC Topic 842 effective August 15, 2019 for the Toronto, Canada office operating lease.

 

Right-of-use assets is summarized below (in thousands):

 

    As of
September 30,
2019
 
Palo Alto, CA Office   $ 178  
Encino, CA Office     188  
Coquitlam, Canada Office     270  
Toronto, Canada Office     367  
Less accumulated amortization     (267 )
Right-of-use asset, net   $ 736  

 

During the three and nine months ended September 30, 2019, the Company recorded $129,196 and $310,921, respectively, as rent expense to the right-of-use assets.

 

Lease liability is summarized below (in thousands):

 

    As of
September 30,
2019
 
Total lease liability   $ 757  
Less: short term portion     (440 )
Long term portion   $ 317  

 

Maturity analysis under the lease agreement is as follows (in thousands):

 

Three months ending December 31, 2019   $ 155  
Year ending December 31, 2020     438  
Year ending December 31, 2021     230  
Total   $ 823  
Less: Present value discount     (66 )
Lease liability   $ 757  

 

Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the date of adoption of Topic 842. As of September 30, 2019, the weighted average remaining lease term is 1.68 years and the weighted average discount rate used to determine the operating lease liabilities was 8.0%.

 

30

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 18 - Commitments and Contingencies

 

Litigation

 

Certain conditions may exist as of the date the consolidated financial statements are issued which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed. 

 

Loss contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed. There can be no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. 

 

Atlas Settlement

 

On February 20, 2019, in connection with the satisfaction of an award in an aggregate amount of $1,156,840 plus pre-judgment interest equal to an aggregate of $59,955 (the “Award”) granted to Atlas Technology Group, LLC (“Atlas”) following arbitration proceedings arising out of an engagement agreement, dated September 8, 2016, by and between Atlas and the Company (including its subsidiaries) (the “Engagement Agreement”), the Company, Sysorex and Atlas entered into a settlement agreement (the “Settlement Agreement”) pursuant to which Atlas agreed to (a) reduce the Award by $275,000 resulting in a “Net Award” of $941,796 and (b) accept an aggregate of 749,440 shares of freely-tradable common stock of the Company (the “Settlement Shares”) in satisfaction of the Award which was determined by dividing 120% of the Net Award by $1.508, which was the “minimum price,” as defined under Nasdaq Listing Rule 5635(d).

 

Pursuant to the Settlement Agreement, after the Company issued and delivered the Settlement Shares to Atlas, the Award was deemed satisfied in full and the parties were deemed to have released each other from any claims arising out of the Engagement Agreement. The Settlement Shares were issued to Atlas pursuant to the Company’s registration statement on Form S-3, as amended (SEC File No. 333-223960), which was declared effective by the SEC on June 5, 2018.

 

In connection with Spin-off of Sysorex, the Company and Sysorex each agreed pursuant to the terms and conditions of that certain Separation and Distribution Agreement, dated August 7, 2018, as amended, that 50% of the costs and liabilities related to the arbitration action arising from the Engagement Agreement would be shared by each party following the Spin-off.  As a result, Sysorex is required to indemnify the Company for half of the total amount paid by the Company to satisfy the Award.

 

Compliance with Nasdaq Continued Listing Requirement

 

On May 30, 2019, we received a deficiency letter from Nasdaq indicating that, based on our closing bid price for the last 30 consecutive business days, we do not comply with the minimum bid price requirement of $1.00 per share, as set forth in Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq listing Rule 5810(c)(3)(A), the Company was provided a period of 180 calendar days, or until November 26, 2019, in which to regain compliance. In order to regain compliance with the minimum bid price requirement, the closing bid price of our common stock must be at least $1.00 per share for a minimum of ten consecutive business days without effecting a reverse split.

 

In addition to the failure to comply with Nasdaq Listing Rule 5550(a)(2), the Nasdaq Staff has advised us that our history of non-compliance with Nasdaq’s minimum bid price requirement, the corresponding history of reverse stock splits, the dilutive effect of the Offering and an inability to cure the bid price deficiency organically without effecting a reverse stock split prior to November 26, 2019 would raise public interest concerns under Nasdaq Listing Rule 5101 and could result in the Nasdaq Staff issuing a delisting determination with respect to our common stock (subject to any appeal the Company may file). Nasdaq rules provide that Nasdaq may suspend or delist particular securities based on any event, condition or circumstance that exists or occurs that makes continued listing of the securities on Nasdaq inadvisable or unwarranted in the opinion of the Nasdaq Staff, even though the securities meet all enumerated criteria for continued listing on Nasdaq. In that regard, the Nasdaq Staff has discretion to determine that our failure to comply with the minimum bid price rule or any subsequent price-based market value requirement or the dilutive effect of the an offering, constitutes a public interest concern and while the Company will have an opportunity to appeal, the Company cannot assure that Nasdaq will not exercise such discretionary authority or that the Company will be successful if such discretion is exercised and the Company appeals.

 

31

 

 

INPIXON AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2019 AND 2018

 

Note 19 - Subsequent Events

 

During the three months ending December 31, 2019, the Company issued 3,126,801 shares of common stock in connection with the exercise of 3,126,801 warrants through cashless exercises.

 

During the three months ending December 31, 2019, the Company issued 625 shares of common stock in connection with the exercise of 625 non-qualified stock options at an exercise price of $0.14 per share for gross proceeds of approximately $87.50.

 

Equity Distribution Agreement

 

On October 10, 2019, the Company entered into an Equity Distribution Agreement with Maxim Group LLC (“Maxim”) under which the Company may offer and sell shares of its common stock having an aggregate offering price of up to $6.5 million from time to time through Maxim, acting exclusively as the Company’s sales agent. The Company intends to use the net proceeds from such sales primarily for working capital and general corporate purposes. The Company may also use a portion of the net proceeds to invest in or acquire businesses or technologies that the Company believes are complementary to its own, although the Company has no current commitments or definitive agreements with respect to any acquisitions as of the date of this Form 10-Q.

 

During the three months ending December 31, 2019, the Company sold 6,415,270 shares of common stock under the Equity Distribution Agreement for net proceeds of approximately $589,000 at sales prices ranging from $0.0794 to $0.116 per share. The Company paid Maxim compensation of approximately $28,000, based on a rate of 4.5% of the gross sales.

 

Exchange Agreements

 

On October 15, 2019, the Company exchanged $200,000 of the outstanding principal and interest under the December 2018 Note for 1,818,182 shares of the Company’s common stock at an exchange price of $0.11 per share.

 

On October 18, 2019, the Company exchanged $200,000 of the outstanding principal and interest under the December 2018 Note for 2,000,000 shares of the Company’s common stock at an exchange price of $0.10 per share.

 

On October 24, 2019, the Company exchanged $195,000 of the outstanding principal and interest under the December 2018 Note for 1,950,000 shares of the Company’s common stock at an exchange price of $0.10 per share.

 

On October 31, 2019, the Company exchanged $240,000 of the outstanding principal and interest under the December 2018 Note for 3,000,000 shares of the Company’s common stock at an exchange price of $0.08 per share.

 

On November 5, 2019, the Company exchanged $202,400 of the outstanding principal and interest under the December 2018 Note for 2,300,000 shares of the Company’s common stock at an exchange price of $0.088 per share.

 

Standstill Agreement Extension

 

As part of the exchange agreement dated October 24, 2019, Iliad agreed to extend the standstill previously agreed to pursuant to the terms of that certain Standstill Agreement, dated as of August 8, 2019, whereby Iliad will not be entitled to redeem all or any portion of the principal amount of the original December 2018 Note until December 31, 2019, and (ii) the maturity date of the Original Note was extended to December 31, 2019.

 

32

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion of our financial condition and results of operations in conjunction with the condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q and with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018, as filed with the SEC. In addition to our historical condensed consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Form 10-Q, particularly in Part II, Item 1A, “Risk Factors.”

 

Overview of our Business

 

We provide a number of different technology products and services relating to Indoor Data including Indoor Positioning, Mapping Analytics and other digital solutions to private and public sector customers. Effective August 31, 2018, the Company completed a Spin-off of Sysorex and the associated Infrastructure business and it is no longer a part of our reporting in the current year. In prior years’ financial data, the revenue and expenses of the Spin-off entities are shown as discontinued operations. Our Indoor Positioning Analytics (“IPA”) products secure, digitize and optimize the interior of any premises with indoor positioning and data analytics that provide rich positional information, similar to a global positioning system, and browser-like intelligence for the indoors. On May 21, 2019, we acquired Locality, a technology company based near Vancouver, Canada, specializing in wireless device positioning and radio frequency (“RF”) augmentation of video surveillance systems and on June 27, 2019, we acquired certain global positioning system (“GPS”) products, software, technologies, and intellectual property from GTX, a U.S. based company specializing in GPS technologies. On August 15, 2019 we acquired Jibestream an indoor intelligent mapping platform company based in Toronto, Canada. These transactions expand our indoor positioning product line. In addition, we offer digital tear-sheets with optional invoice integration, digital ad delivery, and an e-edition designed for reader engagement for the media, publishing and entertainment industry.

 

Revenues increased in the three months ended September 30, 2019 over the same period in 2018 by approximately 63% because of an increase in our IPA revenues resulting from an increased focus on the IPA product line after the Spin-off of our Sysorex business, the acquisitions mentioned above and the addition of a new customer that accounted for approximately 33% of our revenues for the third quarter of 2019. We expect to continue to grow our IPA product line in 2019. The IPA product line does have long sales cycles, which are a result from customer-related issues such as budget and procurement processes but also because of the early stages of indoor-positioning technology and the learning curve required for customers to implement such solutions. Customers also engage in a pilot program first which prolongs sales cycles and is typical of most emerging technology adoption curves. We anticipate sales cycles to improve in 2019 as our customer base moves from early adopters to mainstream customers. The sales cycle is also improving with the increased presence and awareness of beacon and Wi-Fi locationing technologies in the market. IPA sales can be licensed-based with government customers but commercial customers typically prefer a SaaS or subscription model. Our other digital solutions are also delivered on a SaaS model and allow us to generate industry analytics that complement our indoor-positioning solutions.

 

We experienced a net loss of $6.6 million and $5.2 million for the three months ended September 30, 2019 and 2018, respectively, and a net loss of $17.0 million and $17.3 million for the nine months ended September 30, 2019 and 2018, respectively. We cannot assure that we will ever earn revenues sufficient to support our operations, or that we will ever be profitable. In order to continue our operations, we have supplemented the revenues we earned with proceeds from the sale of our equity and debt securities and proceeds from loans and bank credit lines. Furthermore, except for our Payplant facility, we have no committed source of financing and we cannot assure that we will be able to raise money as and when we need it to continue our operations. If we cannot raise funds as and when we need them, we may be required to scale back our business operations by reducing expenditures for employees, consultants, business development and marketing efforts, selling assets or one or more products in our business, or otherwise severely curtailing our operations.

 

33

 

 

Corporate Strategy Update

 

Management continues to pursue a corporate strategy that is focused on building and developing our business as a provider of turnkey solutions ranging from the collection of data to delivering insights from that data to our customers with a focus on securing, digitizing and optimizing premises with our Indoor Positioning, Mapping and Analytics solutions for businesses and governments. In connection with such strategy and in order to facilitate our long-term growth, we are evaluating various strategic transactions and acquisitions of companies with technologies and intellectual property (“IP”) that complement such goals by adding technology, differentiation, customers and/or revenue. We are primarily looking for accretive opportunities that have business value and operational synergies. We believe these complimentary technologies will allow us to provide a comprehensive Indoor Data Platform, or one-stop shop to our customers. We believe that acquiring complementary products and/or IP will add value to the Company. Candidates with proven technologies that complement our overall strategy may come from anywhere in the world, so long as there are strategic and financial reasons to make the acquisition. If we make any acquisitions in the future, we expect that we may pay for such acquisitions using our equity securities, cash and debt financing in combinations appropriate for each acquisition. In connection with this strategy, on May 21, 2019, we acquired Locality, a technology company based near Vancouver, Canada, specializing in wireless device positioning and radio frequency (“RF”) augmentation of video surveillance systems. In addition, on June 27, 2019, we acquired certain global positioning system (“GPS”) products, software, technologies, and intellectual property from GTX, a U.S. based company specializing in GPS technologies. These transactions expand our patent portfolio and includes certain granted or licensed patents and GPS and RF technologies. Furthermore, on August 15, 2019, we acquired Jibestream, a provider of highly configurable intelligent indoor mapping platforms to expand our suite of products.

 

Recent Events

 

Note Exchanges

 

During the third quarter ended September 30, 2019, the Company entered into exchange agreements with Iliad Research and Trading, L.P. pursuant to which it exchanged an aggregate amount of $724,807 of the outstanding balance of the outstanding convertible promissory note issued on December 31, 2018 for partitioned notes and then exchanged such notes for an aggregate of 1,403,772 shares of common stock at exchange prices between $0.51 and $0.532 per share. 

 

Subsequent to the quarter ended September 30, 2019, between October 15, 2019 and November 5, 2019, the Company entered into exchange agreements pursuant to which it exchanged an aggregate amount of $1,037,400 of the outstanding balance of the outstanding convertible promissory note issued on December 21, 2018 for partitioned notes and then exchanged such notes for an aggregate of 11,068,182 shares of common stock at exchange prices between $0.